Cian Healthcare Ltd.
Snapshot View

20.50 ▼0%

22 June 2022, 04:01:00 PM

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.cian.co
Market Cap 51.37 Cr.
Enterprise Value(EV) 119.38 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) -2.21 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 22.21 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.92 Calculated using Price: 20.50
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 2.50 Cr. 24,995,764 Shares
FaceValue 10
Company Profile
The Company develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, along with 10 sales division focused on developing and growing its engagements in specialist and super specialist division. The company works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies. The Company manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet. The Company has special licence for manufacturing veterinary products for client like SAVAvet and Venky's.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
1 Week
+13.89%
1 Month
+24.24%
3 Month
-3.07%
6 Month
+5.13%
1 Year
-19.61%
2 Year
+26.93%
5 Year
10 Year
2 years 2020-03 2021-03
Return on Equity (%) -7.54 0.10
Return on Capital Employed (%) 3.00 6.99
Return on Assets (%) -2.42 0.03

Balance Sheet View Details

Particulars 2 years 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 58 58
Non Curr. Liab. 50 41
Curr. Liab. 48 58
Minority Int.
Equity & Liab. 157 157
Non Curr. Assets 94 88
Curr. Assets 54 63
Misc. Exp. not W/O 8 5
Total Assets 157 157

Profit Loss View Details

Particulars 2 years 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 57 74
Other Income 1 0
Total Income 58 74
Total Expenditure -50 -62
PBIDT 8 12
Interest -7 -8
Depreciation -4 -3
Taxation 0 -1
Exceptional Items 0 0
PAT -4 0
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -4 0
Adjusted EPS -2 0

Cash Flow View Details

Particulars 2 years 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -7 6
Cash Fr. Inv. -27 3
Cash Fr. Finan. 36 -10
Net Change 1 -1
Cash & Cash Eqvt 3 2

Shareholding Pattern View Details

8 Qtrs 2018-09 (%) 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 96.60 70.89 70.89 70.89 70.89 70.89 66.26 66.26
Public 3.40 29.11 29.11 29.11 29.11 29.11 33.74 33.74
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 10.14 10.14 10.14 10.14 20.14 14.11 34.11

Announcements View Details

Tue, 31 May 2022
Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) this is to inform that the Board of Directors of the Company have appointed Mrs. Swati Maheshwari as an Additional Director (Non-Executive Independent) of the Company pursuant to the provisions of the Companies Act 2013 and SEBI Listing Regulations.
Mon, 30 May 2022
Submission Of Audited Financials Results For The Half Year/YearEnded On 31St March 2022
Submission Of Audited Financials Results For The Half Year/YearEnded On 31St March 2022
Mon, 30 May 2022
Board Meeting Outcome for OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF CIAN HEALTHCARE LIMITED ("THE COMPANY") HELD ON MAY 30 2022.
Pursuant to Regulation 33 of SEBI (LODR) Regulations 2015 we are pleased to submit the Audited Financials Results for the Half year/Year ended 31st March 2022 which was also approved by the Board of Directors of the Company at their meeting held on Monday 30th May 2022 at 5:00 P.M. and concluded at 6:55 P.M.

Technical Scans View Details

Wed, 22 Jun 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Cian Healthcare Ltd.

Can I Buy Cian Healthcare Shares now?

What is the Share Price of Cian Healthcare?

What is the Relative Strength Index (RSI) Value of Cian Healthcare?

What is the Market Capital (MCAP) of Cian Healthcare?

What are the key metrics to analyse Cian Healthcare?